The invention provides compounds of general formula ##STR1## wherein R.sup.1, m, Q, T, n, R.sup.2, R.sup.3, V, W, X and R.sup.4 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
CROSS REFERENCE TO RELATED CASES
This application is a continuation application of, and claims priority from, U.S. patent application Ser. No., 09/555,565, filed Jun. 1, 2000 now U.S. Pat. No. 6,518,286, which claims priority from PCT Application No. PCT/SE00/00563, filed Mar. 22, 2000, which claims priority from both Swedish Application No. 99011173, filed Mar. 26, 1999 and Swedish Application No. 99021941, filed Jun. 10, 1999. Each of the above applications is hereby incorporated by reference in its entirety.
Certain thienopyrimidine derivatives are useful for the inhibition of PDE10 enzymes, and thus are useful for treating psychiatric or neurological syndromes, e.g., pyschoses, obsessive-compulsive disorder and/or Parkinson's disease, as well as, for example, treating a disease state modulated by PDE10 activity.
